TY  - GEN
AU  - Onken, Marlies
AU  - Lohse, Lukas
AU  - Coulm, Bénédicte
AU  - Beghin, Delphine
AU  - Richardson, Jonathan L
AU  - Bermejo-Sanchez, Eva
AU  - Aguilera, Cristina
AU  - Bosch, Montserrat
AU  - Cassina, Matteo
AU  - Chouchana, Laurent
AU  - De Santis, Marco
AU  - Duman, Mine Kadioglu
AU  - Gören, M Zafer
AU  - Johnson, Diana
AU  - Bera, Annie Pierre Jonville
AU  - Kaplan, Yusuf C
AU  - Kennedy, Debra
AU  - Kwok, Susan
AU  - Lacroix, Isabelle
AU  - Lepelley, Marion
AU  - Pistelli, Alessandra
AU  - Schaefer, Christof
AU  - Te Winkel, Bernke
AU  - Uysal, Nusret
AU  - Winterfeld, Ursula
AU  - Yakuwa, Naho
AU  - Diav-Citrin, Orna
AU  - Vial, Thierry
AU  - Dathe, Katarina
PY  - 2024
DO  - 10.1111/acps.13643
SN  - 0001-690X
UR  - https://hdl.handle.net/20.500.12105/25565
AB  - Objective: In recent years, safety concerns about modafinil exposure during pregnancy have emerged. In particular, increased risks for major congenital anomalies (MCA) and impaired fetal growth were reported, although study results were conflicting....
LA  - eng
PB  - Wiley
KW  - Congenital abnormalities
KW  - Drug‐related side effects and adverse reactions
KW  - Growth and development
KW  - Modafinil
KW  - Pregnancy
TI  - Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENTIS)
TY  - research article
ER  -